(PRESS RELEASE) PLAINVILLE, MA — Hilco Vision has announced a leadership transition within its Belgium and the Netherlands based ophthalmic subsidiary – Simovision. Filip Chavatte has been named the Managing Director of Simovision effective today, Aug 1, 2022 and will be taking on that role from retiring founder, Marc Simonet.
Mr. Chavatte brings 25 years of healthcare experience at companies including Novartis, GE Healthcare, Baxter, Shire and J&J. He has a track record of delivering outstanding commercial results, developing high performance teams and working in dynamic environments. His broad general management experience includes sales leadership, marketing, planning, account management, KOL partnerships and launching new products.
He commented, “I am honored to be joining Simovision which has a reputation for innovation and service – trusted by hospitals, private clinics, and surgeons alike. Now as part of Hilco Vision I am excited by the runway we have in front of us to continue to innovate and impress our customers and suppliers, while developing the markets in which we operate.”
Mr. Chavatte will be reporting to Ross Brownlee, CEO of Hilco Vision, who added, “We look forward to the impact Filip can have on our growing ophthalmic business. His business acumen, results track record, and people skills promise a very strong future for the company as we develop our ophthalmic capabilities and reach in Europe.”
Marc Simonet will stay on in a strategic advisory capacity, supporting Hilco Vision’s expansion of the innovation and service driven model that has characterized Simovision to this point.